Testing and Linkage to HIV Care in China (CTN 0056)
Testing and Linkage to HIV Care in China: A Clustered Randomized Trial
Sponsor: National Institute on Drug Abuse (NIDA)
This PHASE2/PHASE3 trial investigates HIV and is currently completed. National Institute on Drug Abuse (NIDA) leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
7 versions recorded-
Dec 2025 — Present [monthly]
Completed PHASE2/PHASE3
-
Sep 2025 — Dec 2025 [monthly]
Completed PHASE2/PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
First recorded
Mar 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute on Drug Abuse (NIDA)
- University of California, Los Angeles
For direct contact, visit the study record on ClinicalTrials.gov .